Orchid Pharma Ltd. logo

Orchid Pharma Ltd. (ORCHPHARMA)

Market Closed
10 Aug, 10:00
XNSE XNSE
1,079. 15
+77.3
+7.7157%
26.97B Market Cap
37.45 P/E Ratio
12% Div Yield
221,790 Volume
0 Eps
1,001.85
Previous Close
Add Transaction
Day Range
994 1,089.9
Year Range
480 1,119.8
Want to track ORCHPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ORCHPHARMA closed today higher at ₹1,079.15, an increase of 7.7157% from yesterday's close, completing a monthly increase of 10.123% or ₹99.2. Over the past 12 months, ORCHPHARMA stock gained 40.615%.
ORCHPHARMA is not paying dividends to its shareholders.
The last earnings report, released on May 25, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.26%, based on the last three reports.
Orchid Pharma Ltd. has completed 2 stock splits, with the recent split occurring on Jul 25, 2019.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XNSE (INR).

ORCHPHARMA Chart

People also search for

Wockhardt Ltd.
1,941.6
-1.0902%
Piramal Pharma Ltd.
216.57
+1.3857%
CIE Automotive India Ltd.
409.35
-0.0366%
Ola Electric Mobility Ltd.
40.07
+1.8815%
Natco Pharma Ltd.
924.85
+1.5314%

Orchid Pharma Ltd. (ORCHPHARMA) FAQ

What is the stock price today?

The current price is ₹1,079.15.

On which exchange is it traded?

Orchid Pharma Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is ORCHPHARMA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 12%.

What is its market cap?

As of today, the market cap is 26.97B.

Has Orchid Pharma Ltd. ever had a stock split?

Orchid Pharma Ltd. had 2 splits and the recent split was on Jul 25, 2019.

Orchid Pharma Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Manish Dhanuka CEO
XNSE Exchange
INE191A01027 ISIN
India Country
736 Employees
13 Sep 2012 Last Dividend
25 Jul 2019 Last Split
- IPO Date

Overview

Orchid Pharma Limited is a prominent entity in the pharmaceutical industry, based in Chennai, India. Since its inception in 1992, the company has been at the forefront of developing, manufacturing, and marketing a wide range of pharmaceutical products, including active pharmaceutical ingredients (APIs), bulk actives, finished dosage formulations, and nutraceuticals. Originally operating under the name Orchid Chemicals & Pharmaceuticals Limited, it rebranded to Orchid Pharma Limited in October 2015. Orchid Pharma has carved a niche for itself not only in India but also on an international scale, exporting products to around 40 countries. A significant milestone in its journey was becoming a subsidiary of Dhanuka Laboratories Limited, which has further strengthened its position in the market. The company's dedication to quality and innovation has earned it a reputable stance in the pharmaceutical domain, offering a variety of products across multiple therapeutics areas.

Products and Services

  • Active Pharmaceutical Ingredients (APIs)

    This category encompasses a diverse range of critical ingredients used in the formulation of drugs. Orchid Pharma's portfolio includes oral and injectable cephalosporins, veterinary products, and non-antibiotics. These APIs are pivotal for the company’s multi-therapeutic offerings, catering to anti-infectives, anti-inflammatory, and cardiovascular segments among others.

  • Finished Dosage Formulations

    In addition to APIs, Orchid Pharma specializes in the development and manufacture of finished dosage formulations. These are ready-to-use pharmaceutical products made from active ingredients, designed for consumer use in various therapeutic areas. The company's formulations are distributed domestically and internationally, highlighting its capability to meet global pharmaceutical standards.

  • Nutraceuticals

    Recognizing the importance of nutrition in healthcare, Orchid Pharma offers a range of nutraceutical products. These products include dietary supplements and functional foods that provide health benefits beyond basic nutrition, supporting overall well-being and addressing specific health conditions.

  • Pharmaceutical Research and Development Services

    Orchid Pharma is not just a manufacturing entity; it also contributes to the pharmaceutical industry through its research and development services. The company invests in new drug discovery systems aiming at the continuous improvement and innovation of drugs. This not only demonstrates Orchid Pharma’s commitment to advancing healthcare solutions but also positions it as a key player in pharmaceutical R&D.

Contact Information

Address: SIDCO Industrial Estate
Phone: 91 44 2744 4471